These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1372276)

  • 1. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.
    Jhappan C; Gallahan D; Stahle C; Chu E; Smith GH; Merlino G; Callahan R
    Genes Dev; 1992 Mar; 6(3):345-55. PubMed ID: 1372276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice.
    Tsukamoto AS; Grosschedl R; Guzman RC; Parslow T; Varmus HE
    Cell; 1988 Nov; 55(4):619-25. PubMed ID: 3180222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D; Shankar DB; Lawshé A; Ornitz DM; Shackleford GM; MacArthur CA
    Oncogene; 1998 Nov; 17(21):2711-7. PubMed ID: 9840935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice.
    Lucchini F; Sacco MG; Hu N; Villa A; Brown J; Cesano L; Mangiarini L; Rindi G; Kindl S; Sessa F
    Cancer Lett; 1992 Jul; 64(3):203-9. PubMed ID: 1322235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.
    Stöcklin E; Botteri F; Groner B
    J Cell Biol; 1993 Jul; 122(1):199-208. PubMed ID: 8100231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF; Leder P
    Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.
    Sinn E; Muller W; Pattengale P; Tepler I; Wallace R; Leder P
    Cell; 1987 May; 49(4):465-75. PubMed ID: 3032456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.
    Mangues R; Seidman I; Pellicer A; Gordon JW
    Oncogene; 1990 Oct; 5(10):1491-7. PubMed ID: 2174525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
    Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
    Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
    Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D
    Cancer Res; 1994 Dec; 54(24):6434-40. PubMed ID: 7987839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
    Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ
    Cell; 1990 Jun; 61(6):1147-55. PubMed ID: 2161707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.
    Davies BR; Platt-Higgins AM; Schmidt G; Rudland PS
    Am J Pathol; 1999 Jul; 155(1):303-14. PubMed ID: 10393862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
    Elson A
    Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.